BlackRock, Inc. 13D and 13G filings for ORIC Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
BlackRock Inc. BLK |
5,101,817 7.200% |
0 (Unchanged) |
Filing |
| 2024-10-22 6:06 pm Purchase |
2024-09-30 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
BlackRock Inc. BLK |
5,101,817 7.200% |
2,106,785 (+70.34%) |
Filing |
| 2024-02-07 5:09 pm Sale |
2024-01-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
BlackRock Inc. BLK |
2,995,032 4.500% |
-100,616 (-3.25%) |
Filing |
| 2024-01-29 5:25 pm Purchase |
2023-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
BlackRock Inc. BLK |
3,095,648 5.700% |
2,296,307 (+287.28%) |
Filing |
| 2022-07-08 4:57 pm Sale |
2022-06-30 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
BlackRock Inc. BLK |
799,341 2.000% |
-1,616,006 (-66.91%) |
Filing |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
BlackRock Inc. BLK |
2,415,347 6.100% |
536,439 (+28.55%) |
Filing |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
BlackRock Inc. BLK |
1,878,908 5.300% |
1,878,908 (New Position) |
Filing |